{"id":1084,"date":"2024-11-11T14:29:51","date_gmt":"2024-11-11T19:29:51","guid":{"rendered":"https:\/\/injurycenter.umich.edu\/michigan-safer-opioid-prescribing-toolkit\/?page_id=1084"},"modified":"2026-04-02T10:34:34","modified_gmt":"2026-04-02T14:34:34","slug":"legal-resources","status":"publish","type":"page","link":"https:\/\/injurycenter.umich.edu\/safer-prescribing-toolkit\/legal-resources\/","title":{"rendered":"Legal Resources"},"content":{"rendered":"
\n

Legal Resources<\/h1>\n\n\n

This section includes resources to help healthcare providers navigate opioid-related legal requirements and better understand recent opioid-related legislation.<\/p>\n\n<\/div>\n\n

\n\n

Establishing a \u201cBona Fide\u201d Patient-Provider Relationship<\/h2>\n\n\n
\n
\n\n

As required by Public Act 247 of 2017<\/a>, Michigan prescribers must be in a bona fide prescriber-patient relationship prior to prescribing Schedules 2-5 controlled substances for more than 7 days. As stated in the Public Act 101 of 2018<\/a>, the effective date for the bona fide prescriber-patient relationship is required by 3\/31\/19.<\/p>\n\n<\/div><\/div>\n\n

\n\n

Please refer to the Public Act 249 of 2017<\/a> for sanctions for failing to comply with the new MAPS usage mandates, failure to establish bona fide prescriber-patient relationships, and failure to inform patients regarding the risks associated with prescription opioid drugs.<\/p>\n\n<\/div><\/div>\n<\/div>\n<\/div>\n\n

\n\n

Patient-Provider Pain Management Agreement<\/h2>\n\n\n
\n
\n
\n\n

A pain management agreement is designed to establish a bona fide patient-provider relationship. This agreement can be used for ongoing use of opiate (Narcotic) medication(s) aimed to protect the patient\u2019s access to controlled substances and protect the physician\u2019s ability to prescribe.<\/p>\n\n\n\n

Download a Michigan specific sample Word template<\/a> now:<\/p>\n\n<\/div><\/div>\n\n

\n
\n
\n\n
\"Sample<\/figure>\n\n<\/div><\/div>\n\n
\n\n

Sample Pain Management Agreement<\/a><\/h2>\n\n\n\n

Edit this sample agreement as needed to use in your clinical practice.<\/p>\n\n<\/div><\/div>\n<\/div>\n<\/div><\/div>\n<\/div>\n<\/div>\n<\/div>\n\n

\n\n

Your patients should understand their rights<\/h2>\n\n\n\n

Your patients have rights related to drug use, opioids, and prescribing. At the bottom of this page, you’ll find resources you can share with your patients to help them understand their rights.<\/p>\n\n\n

\n
\n
\n
\n\n
\"Prescription<\/figure>\n\n<\/div><\/div>\n\n
\n\n

Prescription Drug Abuse Policy System<\/a><\/h3>\n\n\n\n

Click on this link to access the Prescription Drug Abuse Policy website which is funded by The National Institute on Drug Abuse to track key state laws related to prescription drug abuse.<\/p>\n\n<\/div><\/div>\n\n

\n\n<\/div><\/div>\n<\/div>\n<\/div>\n\n
\n
\n
\n\n
\"LARA:<\/figure>\n\n<\/div><\/div>\n\n
\n\n

LARA: Summary of Michigan Laws & Regulations<\/a><\/h3>\n\n\n\n

Access a summary of recently passed opioid-related laws in Michigan.<\/p>\n\n<\/div><\/div>\n\n

\n\n<\/div><\/div>\n<\/div>\n<\/div>\n\n
\n
\n
\n\n
\"MI<\/figure>\n\n<\/div><\/div>\n\n
\n\n

MI Automated Prescription System (MAPS)<\/a><\/h3>\n\n\n\n

Click here to access information on a tool used by prescribers and dispensers to track controlled substances, manage patient risk and prevent drug abuse and diversion.<\/p>\n\n\n\n

Create an account or log in to MAPS<\/a><\/p>\n\n<\/div><\/div>\n\n

\n\n<\/div><\/div>\n<\/div>\n<\/div>\n\n
\n
\n
\n\n
\"MAPS<\/figure>\n\n<\/div><\/div>\n\n
\n\n

Download a MAPS Poster for your office or clinic<\/a><\/h3>\n\n\n\n

Display this MAPS poster in your office to inform patients why you check their history in MAPS before prescribing opioid pain relievers.<\/p>\n\n<\/div><\/div>\n\n

\n\n<\/div><\/div>\n<\/div>\n<\/div>\n\n
\n
\n
\n\n
\"\"<\/figure>\n\n<\/div><\/div>\n\n
\n\n

Understanding NarxCare Scores<\/a><\/h3>\n\n\n\n

NarxCare scores is a non-validated tool utilized by MAPS to evaluate patient risk of overdose. Click here for information on interpreting NarxCare scores.<\/p>\n\n\n\n

Disclaimer:<\/em><\/strong> Note that NarxCare scores have not been previously validated.<\/em><\/p>\n\n<\/div><\/div>\n\n

\n\n<\/div><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n\n
\n\n

Informed Consent<\/h2>\n\n\n\n

<\/p>\n\n\n

\n
\n
\n
\n\n
\"Opioid<\/figure>\n\n<\/div><\/div>\n\n
\n\n

Opioid Start Talking Form<\/a><\/h3>\n\n\n\n

As required by Public Act (PA) 246 of 2017<\/a>, the start talking form is designed to satisfy new patient education and parental consent regulations regarding opioid prescriptions starting on 6\/1\/18.<\/p>\n\n\n\n

This form must be completed and saved to the patient\u2019s medical record only when prescribing an Opioid drug.<\/p>\n\n<\/div><\/div>\n\n

\n\n

Download the Word template version of the form now:<\/strong><\/p>\n\n\n\n